ResearcherNewYork–Presbyterian HospitalActive in the last 2 years

Emily Linda Alouani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2303-118X; OpenAlex author ID A5001987997. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study. Co-author DOI 10.1016/j.esmogo.2025.100144 ↗
Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2023.12.24.573257 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alina Cornelia Iuga · 1 shared paper, 2023 · strength 0.17
- Paper Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of p… DOI 10.1101/2023.12.24.573257 ↗
Michael S. May · 1 shared paper, 2023 · strength 0.17
- Paper Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of p… DOI 10.1101/2023.12.24.573257 ↗
Alexander Grenander Raufi · 1 shared paper, 2023 · strength 0.17
- Paper Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of p… DOI 10.1101/2023.12.24.573257 ↗
Raúl Rabadán · 1 shared paper, 2023 · strength 0.17
- Paper Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of p… DOI 10.1101/2023.12.24.573257 ↗
H. Carlo Maurer · 1 shared paper, 2023 · strength 0.17
- Paper Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of p… DOI 10.1101/2023.12.24.573257 ↗
Kenneth P. Olive · 1 shared paper, 2023 · strength 0.17
- Paper Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of p… DOI 10.1101/2023.12.24.573257 ↗
Gulam Abbas Manji · 1 shared paper, 2023 · strength 0.17
- Paper Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of p… DOI 10.1101/2023.12.24.573257 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.